These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6903452)

  • 1. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
    Fuller RW; Hemrick-Luecke SK
    Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pargyline pretreatment on the enhancement of the exocytotic release of norepinephrine during nerve stimulation which is induced by a benzoquinolizine compound with reserpine-like properties.
    Langley AE; Weiner N
    J Pharmacol Exp Ther; 1980 Jun; 213(3):534-8. PubMed ID: 6907314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    Biochem Pharmacol; 1981 Jun; 30(11):1295-8. PubMed ID: 7271828
    [No Abstract]   [Full Text] [Related]  

  • 4. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW; Wong CJ; Hemrick-Luecke SK
    Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):207-21. PubMed ID: 7244360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ro 4-1284 on audiogenic seizure susceptibility and intensity in epilepsy-prone rats.
    Jobe PC; Brown RD; Dailey JW
    Life Sci; 1981 May; 28(18):2031-8. PubMed ID: 6909499
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
    Mishra PK; Dailey JW; Reigel CE; Jobe PC
    Life Sci; 1988; 42(11):1131-7. PubMed ID: 3347143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat.
    Farah MB; Adler-Graschinsky E; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):119-31. PubMed ID: 585416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
    Fuller RW; Hemrick SK
    Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
    [No Abstract]   [Full Text] [Related]  

  • 11. A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover.
    Saner A; Pletscher A
    J Pharmacol Exp Ther; 1977 Dec; 203(3):556-63. PubMed ID: 21955
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of potential antineoplastic agents XXVI: 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]2-quinolizinone derivatives.
    Popp FD; Watts RF
    J Pharm Sci; 1978 Jun; 67(6):871-3. PubMed ID: 248062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of norepinephrine in feeding behavior.
    Rossi J; Zolovick AJ; Davies RF; Panksepp J
    Neurosci Biobehav Rev; 1982; 6(2):195-204. PubMed ID: 6285235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Ro 4-1284 on electrically-induced spinal cord seizures and on spinal cord norepinephrine and 5-hydroxytryptamine levels.
    Jobe PC; Ray TB; Geiger PF; Bourn WM
    Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):601-12. PubMed ID: 243955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline acetyltransferase and acetylcholinesterase activities in mice brain during the antagonistic action of antidepressant drugs and Ro 4--1284.
    Zieliński M; Korczak-Dziuba K; Herman ZS
    Pol J Pharmacol Pharm; 1978; 30(1):29-34. PubMed ID: 25425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugs.
    Saner A; Pletscher A
    J Pharm Pharmacol; 1978 Feb; 30(2):115-7. PubMed ID: 24096
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.
    Colzi A; d'Agostini F; Cesura AM; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S17-20. PubMed ID: 1546133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ways of increasing resistance of renal transplant to thermal ischemia].
    Savchenko NE; Skobeius IA; Soklakov VI; Pilotovich VS
    Urol Nefrol (Mosk); 1977; (5):72-6. PubMed ID: 144344
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs and PGO waves in the lateral geniculate body of the curarized cat. I. PGO wave activity induced by Ro 43284 and by p-chlorophenylalanine (PCPA) as a basis for neuropharmacological studies.
    Ruch-Monachon MA; Jalfre M; Haefely W
    Arch Int Pharmacodyn Ther; 1976 Feb; 219(2):251-68. PubMed ID: 132146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.